Gilead is committed to advancing care for patients around the world, by bringing forward medicines in areas of unmet medical need.
The following links lead to promotional pages
Trodelvy®▼(sacituzumab govitecan)
TECARTUS®▼(brexucabtagene autoleucel)
YESCARTA®▼(axicabtagene ciloleucel)
Contact us
To request medical information, please call +44 (0) 8000 113 700 (UK) / +353 214 825 999 (Ireland) or send us an email at: [email protected].
January 2024 UK-TRO-0915
Adverse events should be reported.
For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or via the Yellow Card app (download from the Apple App Store or Google Play Store). For IE, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead to [email protected] or +44(0) 1223 897500 or +353(0) 21 482 5999.
